0001437749-24-018801.txt : 20240530 0001437749-24-018801.hdr.sgml : 20240530 20240530212926 ACCESSION NUMBER: 0001437749-24-018801 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freiman Paul E. CENTRAL INDEX KEY: 0001410074 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33678 FILM NUMBER: 241007359 MAIL ADDRESS: STREET 1: C/O NOVABAY PHARMACEUTICALS, INC. STREET 2: 5980 HORTON STREET, SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 rdgdoc.xml FORM 4 X0508 4 2024-05-28 0001389545 NovaBay Pharmaceuticals, Inc. NBY 0001410074 Freiman Paul E. C/O NOVABAY PHARMACEUTICALS, INC. 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 1 0 Restricted Stock Units 2024-05-28 4 A 0 30000 0 A Common Stock 30000 30000 D Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. The number of restricted stock units and related contingent right to receive common stock does not give effect to the 1-for-35 reverse stock split the issuer effected on May 30, 2024. /s/ Justin Hall as attorney in fact for Paul E. Freiman 2024-05-30